StockData
Elicio Therapeutics, Inc. logo

Elicio Therapeutics, Inc. (ELTX) stock

ELTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$1.43−0.05 (-3.38%)

Close on Nov 17, 2026Market cap $37.58MP/E –Yield –

Elicio Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Elicio Therapeutics's market cap was $35.70M on Nov 11, 2026, against $161.54M a year earlier. Over the last 5 years it ranged from $1.86M to $231.23M, with a median of $52.19M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$35.70M-74.0%
2025Dec 31, 2025$137.38M+149.8%
2024Dec 31, 2024$55.00M-21.3%
2023Dec 29, 2023$69.88M+2616.1%
2022Dec 30, 2022$2.57M-71.8%
2021Dec 31, 2021$9.14M–

More Elicio Therapeutics figures

See a number that looks wrong?